Dow Down 0.00% Nasdaq Down 0.09%

Agenus Inc. (AGEN)

-NasdaqCM
3.16 0.00(0.00%) 10:43AM EDT - Nasdaq Real Time Price
Prev Close:3.16
Open:3.15
Bid:3.14 x 100
Ask:3.15 x 400
1y Target Est:5.75
Beta:2.16
Next Earnings Date:N/A
Day's Range:3.13 - 3.20
52wk Range:2.27 - 5.27
Volume:32,731
Avg Vol (3m):909,080
Market Cap:198.07M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGEN 0.00%198.07M
ABPIDown 8.33%197.46K
DNDNUp 1.07%219.93M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback